{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:01:12Z","timestamp":1778961672534,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To generate new insights into the biology of Alzheimer\u2019s Disease (AD), we developed methods to combine and reuse a wide variety of existing data sets in new ways. We first identified genes consistently associated with AD in each of four separate expression studies and confirmed this result using a fifth study. We next developed algorithms to search hundreds of thousands of Gene Expression Omnibus (GEO) data sets, identifying a link between an AD-associated gene (NEUROD6) and gender. We therefore stratified patients by gender along with APOE4 status and analyzed multiple SNP data sets to identify variants associated with AD. SNPs in either the region of NEUROD6 or SNAP25 were significantly associated with AD, in APOE4+ females and APOE4+ males, respectively. We developed algorithms to search Connectivity Map (CMAP) data for medicines that modulate AD-associated genes, identifying hypotheses that warrant further investigation for treating specific AD patient subsets. In contrast to other methods, this approach focused on integrating multiple gene expression datasets across platforms in order to achieve a robust intersection of disease-affected genes and then leveraging these results in combination with genetic studies in order to prioritize potential genes for targeted therapy.<\/jats:p>","DOI":"10.1038\/srep14324","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T10:52:41Z","timestamp":1443005561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Leveraging existing data sets to generate new insights into Alzheimer\u2019s disease biology in specific patient subsets"],"prefix":"10.1038","volume":"5","author":[{"given":"Kevin D.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Funt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim N.","family":"Artyomov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Zeskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Kolitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Towfic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"BFsrep14324_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram, L. & Tanzi, R. E. Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 9, 768\u2013778 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFsrep14324_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","volume":"78","author":"C Cruchaga","year":"2013","unstructured":"Cruchaga, C. et al. GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer\u2019s Disease. Neuron 78, 256\u2013268 (2013).","journal-title":"Neuron"},{"key":"BFsrep14324_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset alzheimer\u2019s disease. Cell 153, 707\u2013720 (2013).","journal-title":"Cell"},{"key":"BFsrep14324_CR4","doi-asserted-by":"publisher","first-page":"15148","DOI":"10.1073\/pnas.0404315101","volume":"101","author":"M Krauthammer","year":"2004","unstructured":"Krauthammer, M., Kaufmann, C. A., Gilliam, T. C. & Rzhetsky, A. Molecular triangulation: Bridging linkage and molecular-network information for identifying candidate genes in Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences 101, 15148\u201315153 (2004).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep14324_CR5","unstructured":"Chen, J. Y., Shen, C. & Sivachenko, A. Y. Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac Symp Biocomput 367\u2013378 (2006)."},{"key":"BFsrep14324_CR6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bbrc.2006.08.168","volume":"349","author":"B Liu","year":"2006","unstructured":"Liu, B. et al. Exploring candidate genes for human brain diseases from a brain-specific gene network. Biochemical and Biophysical Research Communications 349, 1308\u20131314 (2006).","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BFsrep14324_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1101\/gr.114280.110","volume":"21","author":"M Soler-Lopez","year":"2011","unstructured":"Soler-Lopez, M., Zanzoni, A., Lluis, R., Stelzl, U. & Aloy, P. Interactome mapping suggests new mechanistic details underlying Alzheimer\u2019s disease. Genome Research 21, 364\u2013376 (2011).","journal-title":"Genome Research"},{"key":"BFsrep14324_CR8","doi-asserted-by":"publisher","first-page":"e78919","DOI":"10.1371\/journal.pone.0078919","volume":"8","author":"L Caberlotto","year":"2013","unstructured":"Caberlotto, L., Lauria, M., Nguyen, T.-P. & Scotti, M. The Central Role of AMP-Kinase and Energy Homeostasis Impairment in Alzheimer\u2019s Disease: A Multifactor Network Analysis. PLoS ONE 8, e78919 (2013).","journal-title":"PLoS ONE"},{"key":"BFsrep14324_CR9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/nn.3262","volume":"15","author":"MA Kheirbek","year":"2012","unstructured":"Kheirbek, M. A., Klemenhagen, K. C., Sahay, A. & Hen, R. Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders. Nat Neurosci 15, 1613\u20131620 (2012).","journal-title":"Nat Neurosci"},{"key":"BFsrep14324_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1309\/AJCPO66OIRULFNLZ","volume":"136","author":"P Kulesza","year":"2011","unstructured":"Kulesza, P., Ramchandran, K. & Patel, J. D. Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer. Am. J. Clin. Pathol. 136, 228\u2013238 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFsrep14324_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl. Acids Res. 37, 1\u201313 (2009).","journal-title":"Nucl. Acids Res."},{"key":"BFsrep14324_CR12","doi-asserted-by":"crossref","unstructured":"Z\u00e1dori, D . et al. Glutamatergic Dysfunctioning in Alzheimer\u2019s Disease and Related Therapeutic Targets. J. Alzheimers Dis. (2014). 10.3233\/JAD-132621","DOI":"10.3233\/JAD-132621"},{"key":"BFsrep14324_CR13","doi-asserted-by":"publisher","first-page":"S527","DOI":"10.3233\/JAD-2010-100501","volume":"20","author":"J Vi\u00f1a","year":"2010","unstructured":"Vi\u00f1a, J. & Lloret, A. Why women have more Alzheimer\u2019s disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. J. Alzheimers Dis. 20 Suppl 2, S527\u2013533 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep14324_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature06758","volume":"452","author":"V Emilsson","year":"2008","unstructured":"Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423\u2013428 (2008).","journal-title":"Nature"},{"key":"BFsrep14324_CR15","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/archneur.65.11.1518","volume":"65","author":"JH Lee","year":"2008","unstructured":"Lee, J. H. et al. Analyses of the National Institute on Aging Late-Onset alzheimer\u2019s Disease Family Study: implication of additional loci. Arch. Neurol. 65, 1518\u20131526 (2008).","journal-title":"Arch. Neurol."},{"key":"BFsrep14324_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11279","volume":"489","author":"A Sanyal","year":"2012","unstructured":"Sanyal, A., Lajoie, B. R., Jain, G. & Dekker, J. The long-range interaction landscape of gene promoters. Nature 489, 109\u2013113 (2012).","journal-title":"Nature"},{"key":"BFsrep14324_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/hmg\/ddg180","volume":"12","author":"LA Lettice","year":"2003","unstructured":"Lettice, L. A. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Human Molecular Genetics 12, 1725\u20131735 (2003).","journal-title":"Human Molecular Genetics"},{"key":"BFsrep14324_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00439-010-0864-x","volume":"128","author":"S Naranjo","year":"2010","unstructured":"Naranjo, S. et al. Multiple enhancers located in a 1-Mb region upstream of POU3F4 promote expression during inner ear development and may be required for hearing. Human Genetics 128, 411\u2013419 (2010).","journal-title":"Human Genetics"},{"key":"BFsrep14324_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneurol.2009.913","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty, M., Beason-Held, L., An, Y., Kraut, M. A. & Resnick, S. M. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch. Neurol. 67, 93\u201398 (2010).","journal-title":"Arch. Neurol."},{"key":"BFsrep14324_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway, S. et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73, 2061\u20132070 (2009).","journal-title":"Neurology"},{"key":"BFsrep14324_CR21","unstructured":"Rogers, M. B. GammagardTM Misses Endpoints in Phase 3 Trial. Alzheimer Research Forum (2013). at &lt;http:\/\/www.alzforum.org\/new\/detail.asp?id=3485&gt; (Date of access: May 2013)"},{"key":"BFsrep14324_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann, A., Tian, L., Henderson, V. W. & Greicius, M. D. Alzheimer\u2019s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE -related risk of developing Alzheimer disease: Sex and APOE -Related AD Risk. Annals of Neurology 75, 563\u2013573 (2014).","journal-title":"Annals of Neurology"},{"key":"BFsrep14324_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb, J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7, 54\u201360 (2007).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep14324_CR24","doi-asserted-by":"publisher","first-page":"e00034","DOI":"10.1042\/AN20100005","volume":"2","author":"M Uittenbogaard","year":"2010","unstructured":"Uittenbogaard, M., Baxter, K. K. & Chiaramello, A. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro 2, e00034 (2010).","journal-title":"ASN Neuro"},{"key":"BFsrep14324_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/labinvest.3780140","volume":"80","author":"SM De la Monte","year":"2000","unstructured":"De la Monte, S. M., Luong, T., Neely, T. R., Robinson, D. & Wands, J. R. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer\u2019s disease. Lab. Invest. 80, 1323\u20131335 (2000).","journal-title":"Lab. Invest."},{"key":"BFsrep14324_CR26","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1073\/pnas.061013598","volume":"98","author":"Y Wang","year":"2001","unstructured":"Wang, Y. et al. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. PNAS 98, 4022\u20134027 (2001).","journal-title":"PNAS"},{"key":"BFsrep14324_CR27","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1212\/WNL.54.11.2072","volume":"54","author":"C Kawas","year":"2000","unstructured":"Kawas, C., Gray, S., Brookmeyer, R., Fozard, J. & Zonderman, A. Age-specific incidence rates of Alzheimer\u2019s disease The Baltimore Longitudinal Study of Aging. Neurology 54, 2072\u20132077 (2000).","journal-title":"Neurology"},{"key":"BFsrep14324_CR28","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"H-K Chen","year":"2011","unstructured":"Chen, H.-K. et al. Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J. Biol. Chem. 286, 5215\u20135221 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFsrep14324_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0006-8993(01)03228-0","volume":"924","author":"CM Lauderback","year":"2002","unstructured":"Lauderback, C. M. et al. Apolipoprotein E modulates Alzheimer\u2019s A\u03b2(1\u201342)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Research 924, 90\u201397 (2002).","journal-title":"Brain Research"},{"key":"BFsrep14324_CR30","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","volume":"2","author":"S Melov","year":"2007","unstructured":"Melov, S. et al. Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau. PLoS ONE 2, e536 (2007).","journal-title":"PLoS ONE"},{"key":"BFsrep14324_CR31","doi-asserted-by":"publisher","first-page":"e1002918","DOI":"10.1371\/journal.pgen.1002918","volume":"8","author":"K Iijima-Ando","year":"2012","unstructured":"Iijima-Ando, K. et al. Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer\u2019s Disease\u2013Related Tau Phosphorylation Via PAR-1. PLoS Genet 8, e1002918 (2012).","journal-title":"PLoS Genet"},{"key":"BFsrep14324_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00702-004-0255-3","volume":"112","author":"Y Tong","year":"2005","unstructured":"Tong, Y. et al. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112, 455\u2013469 (2005).","journal-title":"J Neural Transm"},{"key":"BFsrep14324_CR33","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.1074\/jbc.271.17.10169","volume":"271","author":"PH Frederikse","year":"1996","unstructured":"Frederikse, P. H., Garland, D., Zigler, J. S. & Piatigorsky, J. Oxidative Stress Increases Production of -Amyloid Precursor Protein and -Amyloid (A) in Mammalian Lenses and A Has Toxic Effects on Lens Epithelial Cells. J. Biol. Chem. 271, 10169\u201310174 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFsrep14324_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ncb0111-8","volume":"13","author":"RD Burgoyne","year":"2011","unstructured":"Burgoyne, R. D. & Morgan, A. Chaperoning the SNAREs: a role in preventing neurodegeneration? Nat. Cell Biol. 13, 8\u20139 (2011).","journal-title":"Nat. Cell Biol."},{"key":"BFsrep14324_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/emboj.2011.467","volume":"31","author":"M Sharma","year":"2012","unstructured":"Sharma, M. et al. CSP\u03b1 knockout causes neurodegeneration by impairing SNAP-25 function. EMBO J 31, 829\u2013841 (2012).","journal-title":"EMBO J"},{"key":"BFsrep14324_CR36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-4159.2007.04997.x","volume":"104","author":"DJ Keating","year":"2008","unstructured":"Keating, D. J. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J. Neurochem. 104, 298\u2013305 (2008).","journal-title":"J. Neurochem."},{"key":"BFsrep14324_CR37","doi-asserted-by":"publisher","first-page":"1121.e1","DOI":"10.1016\/j.neurobiolaging.2011.09.021","volume":"33","author":"T Cassano","year":"2012","unstructured":"Cassano, T. et al. Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiology of Aging 33, 1121.e1\u20131121.e12 (2012).","journal-title":"Neurobiology of Aging"},{"key":"BFsrep14324_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.mito.2008.04.004","volume":"8","author":"E Haque","year":"2008","unstructured":"Haque, E. et al. The effect of mutated mitochondrial ribosomal proteins S16 and S22 on the assembly of the small and large ribosomal subunits in human mitochondria. Mitochondrion 8, 254\u2013261 (2008).","journal-title":"Mitochondrion"},{"key":"BFsrep14324_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","volume":"33","author":"R Lugo-Huitr\u00f3n","year":"2011","unstructured":"Lugo-Huitr\u00f3n, R. et al. On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress. Neurotoxicology and Teratology 33, 538\u2013547 (2011).","journal-title":"Neurotoxicology and Teratology"},{"key":"BFsrep14324_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj, E., Pawlak, K., Bien, B. & Pawlak, D. Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Advances in Medical Sciences 55, 204\u2013211 (2010).","journal-title":"Advances in Medical Sciences"},{"key":"BFsrep14324_CR41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling, D. et al. Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration. Cell 145, 863\u2013874 (2011).","journal-title":"Cell"},{"key":"BFsrep14324_CR42","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1074\/jbc.M112.426536","volume":"288","author":"GT Corbett","year":"2013","unstructured":"Corbett, G. T., Roy, A. & Pahan, K. Sodium Phenylbutyrate Enhances Astrocytic Neurotrophin Synthesis via Protein Kinase C (PKC)-mediated Activation of cAMP-response Element-binding Protein (CREB) IMPLICATIONS FOR ALZHEIMER DISEASE THERAPY. J. Biol. Chem. 288, 8299\u20138312 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFsrep14324_CR43","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/npp.2008.229","volume":"34","author":"A Ricobaraza","year":"2009","unstructured":"Ricobaraza, A. et al. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer\u2019s disease mouse model. Neuropsychopharmacology 34, 1721\u20131732 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"BFsrep14324_CR44","doi-asserted-by":"publisher","first-page":"e21788","DOI":"10.1371\/journal.pone.0021788","volume":"6","author":"J Yao","year":"2011","unstructured":"Yao, J., Chen, S., Mao, Z., Cadenas, E. & Brinton, R. D. 2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function and Reduces Pathology in Female Mouse Model of Alzheimer\u2019s Disease. PLoS ONE 6, e21788 (2011).","journal-title":"PLoS ONE"},{"key":"BFsrep14324_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/JMN:19:3:301","volume":"19","author":"R Loy","year":"2002","unstructured":"Loy, R. & Tariot, P. N. Neuroprotective properties of valproate: potential benefit for AD and tauopathies. J. Mol. Neurosci. 19, 303\u2013307 (2002).","journal-title":"J. Mol. Neurosci."},{"key":"BFsrep14324_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1567205011310030005","volume":"10","author":"Z Long","year":"2013","unstructured":"Long, Z. et al. Valproic acid attenuates neuronal loss in the brain of APP\/PS1 double transgenic Alzheimer\u2019s disease mice model. Curr Alzheimer Res 10, 261\u2013269 (2013).","journal-title":"Curr Alzheimer Res"},{"key":"BFsrep14324_CR47","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing, H. et al. Valproic acid inhibits Abeta production, neuritic plaque formation and behavioral deficits in Alzheimer\u2019s disease mouse models. J. Exp. Med. 205, 2781\u20132789 (2008).","journal-title":"J. Exp. Med."},{"key":"BFsrep14324_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2013.01.001","volume":"537","author":"H Nie","year":"2013","unstructured":"Nie, H. et al. New nicotinic analogue ZY-1 enhances cognitive functions in a transgenic mice model of Alzheimer\u2019s disease. Neurosci. Lett. 537, 29\u201334 (2013).","journal-title":"Neurosci. Lett."},{"key":"BFsrep14324_CR49","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.nbd.2010.07.002","volume":"40","author":"L Diomede","year":"2010","unstructured":"Diomede, L. et al. Tetracycline and its analogues protect Caenorhabditis elegans from \u03b2 amyloid-induced toxicity by targeting oligomers. Neurobiol. Dis. 40, 424\u2013431 (2010).","journal-title":"Neurobiol. Dis."},{"key":"BFsrep14324_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1742-2094-9-62","volume":"9","author":"MT Ferretti","year":"2012","unstructured":"Ferretti, M. T., Allard, S., Partridge, V., Ducatenzeiler, A. & Cuello, A. C. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology. J Neuroinflammation 9, 62 (2012).","journal-title":"J Neuroinflammation"},{"key":"BFsrep14324_CR51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1152\/physiolgenomics.00242.2007","volume":"33","author":"WS Liang","year":"2008","unstructured":"Liang, W. S. et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer\u2019s disease: a reference data set. Physiological Genomics 33, 240\u2013256 (2008).","journal-title":"Physiological Genomics"},{"key":"BFsrep14324_CR52","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock, E. M. et al. Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 101, 2173\u20132178 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep14324_CR53","unstructured":"Nakabeppu, Y. & Hokama, M. Expression data from post mortem Alzheimer\u2019s disease brains (GSE36980). (2013). at &lt;http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE36980&gt; (Date of access: May 2013)."},{"key":"BFsrep14324_CR54","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajhg.2009.03.011","volume":"84","author":"JA Webster","year":"2009","unstructured":"Webster, J. A. et al. Genetic Control of Human Brain Transcript Expression in Alzheimer Disease. The American Journal of Human Genetics 84, 445\u2013458 (2009).","journal-title":"The American Journal of Human Genetics"},{"key":"BFsrep14324_CR55","doi-asserted-by":"crossref","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article3 (2004).","DOI":"10.2202\/1544-6115.1027"},{"key":"BFsrep14324_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. et al. Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249\u2013264 (2003).","journal-title":"Biostatistics"},{"key":"BFsrep14324_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2013analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"BFsrep14324_CR58","unstructured":"Myers, A. Laboratory of Functional Neurogenomics Website at &lt;http:\/\/labs.med.miami.edu\/myers\/LFuN\/data.html&gt; (Date of access: March 2013)."},{"key":"BFsrep14324_CR59","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062\u20136067 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep14324_CR60","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","volume":"10","author":"C Wu","year":"2009","unstructured":"Wu, C. et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology 10, R130 (2009).","journal-title":"Genome Biology"},{"key":"BFsrep14324_CR61","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. The American Journal of Human Genetics 81, 559\u2013575 (2007).","journal-title":"The American Journal of Human Genetics"},{"key":"BFsrep14324_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFsrep14324_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/prot.22527","volume":"78","author":"L P\u00e9rez-Cano","year":"2010","unstructured":"P\u00e9rez-Cano, L. & Fern\u00e1ndez-Recio, J. Optimal protein-RNA area, OPRA: a propensity-based method to identify RNA-binding sites on proteins. Proteins 78, 25\u201335 (2010).","journal-title":"Proteins"},{"key":"BFsrep14324_CR64","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkl819","volume":"34","author":"OTP Kim","year":"2006","unstructured":"Kim, O. T. P., Yura, K. & Go, N. Amino acid residue doublet propensity in the protein-RNA interface and its application to RNA interface prediction. Nucleic Acids Res. 34, 6450\u20136460 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep14324_CR65","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/bioinformatics\/btq253","volume":"26","author":"Z-P Liu","year":"2010","unstructured":"Liu, Z.-P., Wu, L.-Y., Wang, Y., Zhang, X.-S. & Chen, L. Prediction of protein-RNA binding sites by a random forest method with combined features. Bioinformatics 26, 1616\u20131622 (2010).","journal-title":"Bioinformatics"},{"key":"BFsrep14324_CR66","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes and Disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep14324","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep14324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T09:19:02Z","timestamp":1718097542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep14324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,26]]}},"alternative-id":["BFsrep14324"],"URL":"https:\/\/doi.org\/10.1038\/srep14324","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]},"assertion":[{"value":"20 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employees, advisors, and\/or stockholders of Immuneering. Immuneering has applied for patent protection on the reported methods\/findings.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14324"}}